Heron Therapeutics Inc (HRTX)

R&D Expenses

$12.30M

TTM · Period ending: · USD

HRTX logo

HRTX R&D Expenses

Latest reported$12.30M
HRTX R&D Expenses ($0.00 → $12.30M)
High-resolution chart · PNG

HRTX r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
12,429,000
16,683,000
39,133,000
82,704,000
130,821,000
174,533,000
167,382,000
140,032,000
138,582,000
103,125,000
61,183,000
54,833,000
32,780,000
15,045,000
8,207,000
7,264,000
7,796,000
19,507,000
19,364,000
15,236,000
10,299,000
11,495,000
8,660,000
6,699,000
7,348,000
3,713,000
4,300,000
4,400,000
3,700,000
3,500,000
4,100,000
6,300,000
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.